Overview

A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants

Status:
Completed

Trial end date:
2021-08-17

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the effect of multiple-doses of itraconazole, phenytoin and paroxetine on the single-dose pharmacokinetics (PK) of poziotinib in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Spectrum Pharmaceuticals, Inc

Treatments:

Itraconazole
Paroxetine
Phenytoin